title: Study of the osteoconductive capacity of hydroxyapatite implanted into the femur of ovariectomized rats.
abstract: Osteoporosis is a global public health that affects postmenopausal women due to the deficiency of estrogen, a hormone that plays an important role in the microarchitecture of bone tissue. Osteoporosis predisposes to pathological bone fracture that can be repaired by conventional methods. However, depending on the severity and quantity of bone loss, the use of autogenous grafts or biomaterials such as hydroxyapatite might be necessary. The latter has received increasing attention in the medical field because of its good biological properties such as osteoconductivity and biocompatibility with bone tissue. The objective of this study was to evaluate using histologic and radiographic analyses, the osteogenic capacity of hydroxyapatite implanted into the femur of rats with ovariectomy-induced osteoporosis. Eighteen rats were divided into three groups with six animals in each: group nonovariectomized, bilaterally ovariectomized not receiving estrogen replacement therapy, and bilaterally ovariectomized submitted to estrogen replacement therapy. Defects were created experimentally in the distal epiphysis of the femur with a surgical drill and filled with porous hydroxyapatite granules. The animals were sacrificed 8 weeks after surgery. The volume of newly formed bone in the implant area was quantified by morphometrical methods. The results were analyzed by ANOVA followed by the Tukey test (P < 0.05). The hydroxyapatite granules showed good radiopacity. Histological analysis revealed less quantity of newly formed bone in the ovariectomized group not submitted to hormone replacement therapy. In conclusion, bone neoformation can be expected even in bones compromised by estrogen deficiency, but the quantity and velocity of bone formation are lower.
authors.affiliation: Departamento de Morfologia e Patologia Básica da Faculdade de Medicina de Jundiaí, Rua Francisco Telles, 250, Vila Arens, Jundiaí-SP, Brazil.
authors.forename: Daniele Cristina
authors.initials: DC
authors.lastname: Do Prado Ribeiro
authors.forename: Luanda
authors.initials: L
authors.lastname: de Abreu Figueira
authors.forename: João Paulo Mardegan
authors.initials: JP
authors.lastname: Issa
authors.forename: Cesar Adriano
authors.initials: CA
authors.lastname: Dias Vecina
authors.forename: Fernando
authors.initials: F
authors.lastname: Josédias
authors.forename: Marcelo Rodrigues
authors.initials: MR
authors.lastname: Da Cunha
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001861:Bone Regeneration; D017886:Durapatite / Q000008:administration & dosage* / Q000494:pharmacology; D004838:Epiphyses / Q000000981:diagnostic imaging / Q000187:drug effects / Q000293:injuries / Q000473:pathology; D004958:Estradiol / Q000494:pharmacology; D015914:Estrogen Replacement Therapy; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000293:injuries / Q000473:pathology; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy* / Q000473:pathology; D010052:Ovariectomy; D011859:Radiography; D051381:Rats
chemical_list: D004958:Estradiol; D017886:Durapatite